赛诺菲-JPM-20240109.pdf

《赛诺菲-JPM-20240109.pdf》由会员分享，可在线阅读，更多相关《赛诺菲-JPM-20240109.pdf（16页珍藏版）》请在三个皮匠报告上搜索。

1、J.P.MorganHealthcare ConferencePaul Hudson,CEOJanuary 9,2024This document contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995,as amended.Forward-looking statements are statements that are not historical facts.These statements include projections and

2、 estimates and their underlying assumptions,statements regarding plans,business transformations,objectives,intentions and expectations with respect to future financial results,events,operations,services,product development and potential,and statements regarding future performance.Forward-looking sta

3、tements are generally identified by the words“expects”,“anticipates”,“believes”,“intends”,“estimates”,“plans”,“potential”,“outlook”,“guidance”and similar expressions.Although Sanofis management believes that the expectations reflected in such forward-looking statements are reasonable,investors are c

4、autioned that forward-looking information and statements are subject to various risks and uncertainties,many of which are difficult to predict and generally beyond the control of Sanofi,that could cause actual results and developments to differ materially from those expressed in,or implied or projec

5、ted by,the forward-looking information and statements.These risks and uncertainties include among other things,the uncertainties inherent in research and development,future clinical data and analysis,including post marketing,decisions by regulatory authorities,such as the FDA or the EMA,regarding wh

6、ether and when to approve any drug,device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates,the fact that product candidate